Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016)

NCT05289271 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Vaccines, Combined
Hexavalent Vaccine

Interventions

BIOLOGICAL: Vaxelis™

Sponsor

Merck Sharp & Dohme LLC